Patrys Limited

ASX:PAB ISIN:AU000000PAB9

Patrys Limited (ASX:PAB) is an Australia-based company. The principal activity of the Company is to develop natural human antibody based therapeutic products for the treatment of cancer and other diseases. 
 
    

View in Other Languages

News

Australian Market Report of August 2, 2010

🕔8/2/2010 1:30:45 PM 11482

The Australian share market begins the week with a slightly stronger opening without being affected by a flat lead from Wall Street. In early trade, Gold and Financial stocks were positive after the opening bell.

Read Full Article
###

32,808 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 52) (Since Published: 6974) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • None 

More News Results

  • 2024/12/16: Patrys Receives R&D Tax Incentive Refund*
  • 2024/11/22: Results of Annual General Meeting*
  • 2024/11/22: Chair's Address and CEO Presentation to 2024 AGM*
  • 2024/10/30: Appendix 4C - Quarterly - 30 September 2024*
  • 2024/10/21: Notice of Annual General Meeting/Proxy Form*
  • 2024/10/14: Notification of cessation of securities - PAB*
  • 2024/10/02: PAT-DX1 clinical development update*
  • 2024/09/20: PAT-DX1 GMP specification testing update*
  • 2024/08/29: PAT-DX1 GMP specification testing update*
  • 2024/08/23: Appendix 4G and Corporate Governance Statement*
*refer to company website